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Abstract 
Anti-bacterial, anti-inflammatory and anti-adhesive coatings for urinary catheters 
Ce Zhou 
 
 
Patients with permanent injury or severe illness may need a long term use of 
urinary catheters. Catheter insertion and long-term catheterization carries a significant 
risk of catheter-associated urinary tract infection (CAUTI) and inflammatory reaction 
around inner urethra. In this study we developed novel antibacterial, anti-inflammatory, 
and anti-adhesive coatings based on layer-by-layer (LbL) assembly for effective 
prevention of infection and inflammation associated with urinary catheters. We tested 
different base layers to improve the surface wettability and charge of polyvinyl chloride 
(PVC) urinary catheters for subsequent LbL assembly including different layers of 
polyethyleneimine (PEI), Dopamine (DA), and alternate adsorption of PEI and 
polystytene sulfonate (PSS), and found that 10 bilayers of PEI/PSS-coated catheters 
demonstrated the highest surface wettability and positive charges. We subsequently 
built a novel anti-bacterial, anti-inflammatory LbL coating impregnated with 
minocycline hydrochloride (MH), an antibiotic and anti-inflammatory drug on this base 
layer. MH was incorporated in the LbL assembly based on a novel calcium binding-
mediated interactions, which in combination with protective LbL layers, allows 
sustained release of MH in urine for over 33 days. In particular, initial colonization of 
three CAUTI related bacterial biofilm, Escherichia coli (E.coli), Acinetobacter 
baumannii (A. Baumannii) and Staphylococcus aureus (S.aureus), was significantly 
inhibited on catheters coated by MH-releasing LbL coating. Additionally, we developed 
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an anti-adhesive LbL coating by alternate adsorption of anti-adhesive poly(l-glutamic 
acid)-grafted-poly(ethylene glycol) (PGA-g-PEG) and gelatin. The adhesion of bovine 
serum albumin, bacteria, and macrophages on 8 bilayers of PGA-g-PEG/gelatin was 
greatly reduced.  
 
 
 
 
  
 
 
 
 
INTRODUCTION 
1. Urinary catheters and CAUTI 
Each year, there are more than 5 million patients who need urinary catheters[1]. 
The urinary catheter system consisted of a tube inserted into the bladder through the 
urethra to drain urine into a container (Fig.1). Catheter insertion and long-term 
catheterization carries a significant risk of catheter-associated urinary tract infection 
(CAUTI). CAUTI is the second most common cause of nosocomial bloodstream 
infection. Patients requiring. Approximately 25% of hospitalized patients requiring 
indwelling urinary catheterization for more than 7 days developed nosocomial 
bacteriuria or candiduria at a daily risk of 5% [2]. Catheter-associated urinary infections 
(CAUTI) accounts for 30% to 40% of nosocomial infections resulting in morbidity and 
increased length of hospital stay by 1 to 3.8 days [3]. The primary cause of CAUTI is 
biofilm formation by pathogens assembled on urinary catheters. The formation of 
biofilm may increase the resistance to antibiotics. Current methods to prevent biofilm 
formation are inadequate. Since biofilm plays a major part in the pathogenesis of 
CAUTI, as well as their high morbidity, mortality, clinical and economic significance, 
much effort have been made to prevent biofilm formation by modification of catheter 
surface, such as coating diverse biocompatible materials on the surface on the 
catheters[4, 5]. Recently, catheters coated with silver alloy have been applied to clinical 
use, based on the antiseptic ability that silver has exhibited in vitro [4, 6, 7]. However, 
one silver alloy urinary catheter cost about $6 more than standard catheter [6]. Another 
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potential concern with the use of silver on catheter coatings is argyrism [8]. An 
alternative strategy is to use antibiotic-impregnated coatings. Catheters impregnated 
with a combination of rifampicin and minocycline have been found to be effective in 
reducing catheter-associated bacteriuria [9]. However, rifampicin is highly toxic [10] 
which makes it more suitable for treatment, not prevention. Additionally, the 
widespread use of rifampicin may cause increased rates of drug-resistant tuberculosis 
[8]. Thus, more economic and safer coatings are required for clinical use.  
Another possible consequence that may occur during urinary catheter insertion and 
long-term use is inflammation, which is caused by bacterial infection and the foreign 
body reaction[11], resulting in inflammation around inner urethra. This foreign body 
response is caused by non-specific immune response to implanted foreign materials. It 
is characterized by the inflammatory cells to the area to destroy or remove the foreign 
materials. However, since the implants cannot be removed or destroyed, the 
inflammatory response will persist [12]. Traditional administration of anti-
inflammatory agents is often ineffective in treating implant-induced local inflammation 
Currently urinary catheters are made of silicone, rubber, latex or polyvinyl chloride 
(PVC). Urinary catheters with hydrophilic surface coating reduce the risk of biofilm 
aggregation, as well as protein adsorption and cell adhesion. People with a permanent 
injury or severe illness may need a long time use of urinary catheters. Short period of 
catheter usage may not cause a problem, however, long-term use of urinary catheters 
may cause CAUTI. The pathogenic biofilm can easily formed on the surface of the 
indwelling urinary catheter due to the moist environment. The indwelling urinary 
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catheter normally cannot be cleared of a pathogenic biofilm by antibiotics without 
removing the catheter[4]. As the colonized catheter remains inside the urethra, biofilm-
associated bacteria can enter the urine to infect the whole urinary system. Studies have 
shown that infection occurs within four days when open catheters are used [13]. On one 
hand, some patients with severe illness or no consciousness cannot avoid from long 
term use of open catheters, on the other hand, oral or injectable antibiotics and anti-
inflammatory drugs often have a low efficiency in finding the target and even cause 
severe side effects. Sustained local drug delivery system coated on urinary catheters 
offers a desirable local drug delivery system to effectively inhibit CAUTI. 
Fig.1 Use of urinary catheters 
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2. Loading drug with electrostatic layer-by-layer assembly 
Hydrophilic coatings have been shown to minimize nonspecific protein adsorption 
and inflammatory cell adhesion that would exacerbate the foreign body response [14].  
 
As free energy is minimized when proteins stick to surfaces compared to being 
surrounded by water molecules, hydrophilic surfaces have a lower protein adsorption. 
Thus, the ability to coat a hydrophilic film on hydrophobic catheter surface is a crucial 
step for the following study of cell/bacterial/protein –biomaterial interactions. Several 
surface modifications have been reported, including plasma modification[15], and 
chemical modification[16]. Plasma modification brings in a high-quality thin film, but 
inner surface of tubing cannot be accessed easily by this method. Electrostatic layer-
by-layer (LbL) method, however, is based on alternate adsorption of oppositely charged 
components onto solid substrates, has been developed to coat nanometer-thick 
organized films on any surface [17-19].  
Minocycline Hydrochloride (MH) is a broad-spectrum tetracycline antibiotic and 
long-acting effective anti-inflammatory drug that is widely used to treat infection and 
inflammation [20], making it a promising drug candidate to treat implant-associated 
infection and inflammation by layer-by-layer (LbL) local delivery. Our lab has 
previously developed a novel hydrophilic multilayer thin film coating capable of 
sustained release of MH in Hank’s Balanced Salt Solution (HBSS) for over 35 days 
based on a novel calcium binding-mediated drug delivery mechanism. MH can chelate 
divalent metal ions such as Ca2+ and Mg2+, without affecting its biological activities 
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[21]. Dextran sulfate (DS) is a biocompatible and biodegradable polysaccharide that 
also has a high binding affinity for Ca2+ due to its numerous negatively charged sulfate 
groups [22]. Utilizing this property, our lab used Ca2+ as the linker to attach MH to DS. 
We further found that DS can form electrostatic layer-by-layer (LbL) with gelatin type 
A (GA), a positively charged biocompatible, biodegradable natural polymer derived 
from collagen. Based on our lab’s previous work, multilayers of DS-Ca2+-MH 
conjugate/GA were successfully constructed to form hydrophilic coatings. However, 
MH release from 20 trilayers of LbL films only lasted for 18 days in urine. To prolong 
MH release, we added alginate sulfate (AS) and glycol-chitosan (GC) to the trilayers 
system (Fig.2A) to server as barriers to impede MH release. MH release from 20 
pentalayer of LbL film into urine was increased to 33 days using this strategy.  
Successful deposition of the hydrophilic MH-releasing LbL coating onto a urinary 
catheter requires a hydrophic and charged surface. However, the PVC urinary catheter 
used in this study is hydrophobic and neutrally charged, which doesn’t support charged 
hydrophilic polymer adhesion. Thus, the catheter surface needs to be modified to create 
a charged and hydrophilic surface for subsequent LbL assembly. Polyethyleneimine 
(PEI) is a positively charged polymer due to the numerous amine groups [5]. 
Polystyrene sulfonate (PSS) is a negatively charged polymer because of the sulfonic 
acid or sulfonate side groups [5]. Multilayer of alternating cationic PEI and anionic PSS 
has been used as the base layer for LbL assembly [5]. PEI/PSS ending by PEI can 
potentially improve the wettability of catheter surface and make it positively charged 
by providing the surface with amine groups, making it a good candidate for a base layer. 
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Dopamine (DA), a small molecule compound that contains mussel adhesive functional 
groups, can form both strong covalent and no-covalent interactions with diverse 
substrates [23]. DA also contains numerous amine groups which provide coated surface 
with positive charges. 
 
Fig 2 (A) Scheme of MH pentalayers LbL assembly. (B) Scheme of anti-adhesive 
LbL assembly. 
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3. Role of polyethylene glycol (PEG) in anti-protein adsorption, anti-cell 
adhesion and anti-bacterial adhesion 
Proteins are prone to adhere to the surface of medical devices due to reduced free 
energy [24]. Adhered proteins play an essential role in the initial adhesion of bacteria 
and inflammatory cells on a biomaterial surface [25], the first step in biofilm formation 
and foreign body response. Infection and inflammation are common causes for the 
failure of many medical implants [26]. Tremendous research effort has been made to 
develop strategies to resist protein adsorption and subsequent bacteria and cellular 
adhesion on medical devices [27, 28]. Surface modification to combat these undesirable 
interactions are usually chosen based on the application of the medical devices and 
underlying material. Our molecule that has shown great “non-fouling” potential is 
polyethylene glycol (PEG) [25]. PEG is a biocompatible non-ionic polymer that resists 
protein adsorption and cell adhesion due to its strong affinity for water molecules [29]. 
However, it cannot be incorporated into electrostatic LbL due to lack of charges. One 
study reported coupling of PEG to poly(L-glutamic acid)(PGA) to obtain negatively 
charged poly(l-glutamic acid)-grafted-poly(ethylene glycol) (PGA-g-PEG) [29]. In the 
same study a multilayer of poly(l-lysine) (PLL)/PGA-g-PEG was built and 
demonstrated to reduce both protein and bacterial adhesion. However, while 
immobilized PLL has been commonly used for cell culture, free PLL has been reported 
to have cytotoxicity [30]. Since PGA is degradable, PLL can be released from the 
multilayer film and becomes cytotoxic. In the present study we tested replacing PLL 
with gelatin type A (GA) or chi to improve the safety of the anti-adhesive LbL film. We 
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found that multilayers of GA/PGA-g-PEG demonstrated higher anti-adhesive 
capability than chi/PGA-g-PEG. Escherichia coli (E.coli), Acinetobacter baumannii (A. 
Baumannii) and Staphylococcus aureus (S.aureus) are the common pathogens that 
cause CAUTI [31]. 8 bilayers of GA/PGA-g-PEG (Fig.2B) deposited urinary catheters 
significantly inhibited protein adsorption, biofilm formation by all three bacteria 
species, and macrophage adhesion. This anti-adhesive coating, in combination with the 
MH-releasing coating, is highly promising to effectively prevent infection and 
inflammation associated with indwelling urinary catheters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
MATEIRALS AND METHODS 
1. Materials 
Dextran Sulfate (DS), Minocycline Hydrochloride (MH), Gelatin type A (GA), 
Alginate Sulfate (AS), Glyco-Chitosan (GC), Polyethelineimine (PEI), Polystyrene 
Sulfonate (PSS), and Dopamine (DA) were purchased from Sigma-Aldrich. 
Paraformaldehyde (PFA) 16% solution was purchased from Electron Microscopy 
Sciences. Trypone Soya Broth (TSB) was purchase from Oxoid. Nutrient Agar was 
purchased from Remel. 4',6-diamidino-2-phenylindole (DAPI) was purchased from 
Invitrogen. PVC catheters were obtained from C.R. Bard, Inc (Covington, GA). HPLC-
grade methanol, acetonitrile, phosphate were obtained from Sigma-Aldrich (St. Louis, 
MO, USA). All the other reagents were at their highest purity and water was deionized 
water (DI). PVC latex-free urethral catheters were from Bard.  
 
RAW264.7 murine macrophages were provided by Dr. Narayan Avadhani, 
University of Pennsylvania. Urine was collected from healthy volunteers from Drexel 
University and sterilized by 0.22μm filter. Escherichia coli (ATCC 25922), 
Acinetobacter baumannii (ATCC 19606), and Staphylococcus aureus (ATCC 25923) 
strains were purchased from American Type Culture Collection (ATCC, Manassas, 
VA). A multi-drug resistance Acinetobacter baumannii clinical isolate (referred as A. 
baumannii #22) was locally isolated from a hospitalized patient having invasive device-
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associated infection following a protocol approved by the Institutional Review Board 
of Drexel University. 
2. Preparation of PEG-PGA conjugate 
2.1 PEG-NH2 conjugate 
200mg PEG was dissolved in 10 mL dimethylformamide (DMF). 323mg 1,1’-
carbonyldiimidazole was mixed in the PEG solution. The reaction was allowed to 
proceed with stirring for 2 h at room temperature. Subsequently, 5 mL of 
ethylenediamine was added and the reaction was allowed to proceed with stirring for 
24 h at room temperature. 10mL deionized (DI) water was added to stop the reaction 
and the reaction mixture was dialyzed against DI water for at least 18 h with at least 3 
buffer changes. The product was lyophilized and stored at -20 ̊C.  
2.2 Graft PEG onto PGA 
40 mg of PGA, 95.2 mg of PEG-NH2 and 2 mg of NHS were dissolved in 2ml of 
buffer, 100mM sodium tetraborate (pH=8.5). EDC (14.6 mg) was dissolved in the 
mixture with stirring. The reaction was allowed to proceed at room temperature for 6 h. 
After filtration, the reaction mixture was dialyzed for 24 h, first against phosphate 
buffer (0.1 M, pH=7.4, Na2HPO4/NaH2PO4) and subsequently against DI water. PEG-
PGA was lyophilized and stored at −20°C [29]. 
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3. Catheter Surface Modification 
3.1 Base layer 
Solutions of PEI and PSS were prepared in CaCl2 solution with a concentration of 
0.8mg/mL in deionized (DI) water. The urinary catheters were coated with 10 layers of 
polyethyleneimine (PEI) incorporated with polystyrene sulfonate (PSS) or 10 layers of 
Dopamine as base layers  
3.2 LbL assembly of MH-releasing multilayer film 
MH-releasing multilayer films were deposited on UV-transparent 96 well plates 
for characterization of MH incorporation and film growth by UV absorption, or on PVC 
catheters for release study. 1 mg/ml solutions of DS, MH, GA, AS and GC were 
prepared in 0.8 mg/mL CaCl2 in deionized (DI) water solution. The substrates The 
substrates were first coated with 10 bilayers of PEI/PSS as an initiating positively 
charged base layer, followed by alternating immersion in solutions of DS, MH, GA, AS 
and GC for 10 min. The excess molecules were removed by rinsing the substrates with 
DI water for 1 min between each step. 
3.3 LbL assembly of anti-adhesive multilayer film 
Anti-adhesive multilayer films were deposited on PVC catheters. 1 mg/ml 
solutions of PGA-g-PEG and GA were prepared in 0.8 mg/mL CaCl2 in DI water 
solution. The substrates were first coated with 10 bilayers of PEI/PSS as an initiating 
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positively charged base layer, followed by alternating immersion in solutions of PGA-
g-PEG and GA for 10 min. The excess molecules were removed by rinsing the 
substrates with DI water for 1 min between each step. 
4. Surface Characterization 
4.1 Measurement of contact angle 
Advancing contact angle measurements were performed on bare catheters and 
coated catheters via the sessile drop technique[32] using goniometer(Dataphysics). 
Each data point was tested with approximately 1ul of double-distilled deionized water, 
based on 3 contact angle measurements at 3 different positions on the catheter specimen.  
4.2 Measurement of surface density of amino groups 
In order to determine how many amino groups were there on the surface of 
modified catheters, sulfo-SDTB was employed. The reaction between sulfo-SDTB and 
amino groups on the modified catheters results in stable bonds at alkaline conditions. 
1.5mg sulfo-SDTB was dissolved in 0.5mL DMF, and diluted to 25mL in 50mM 
sodium bicarbonate buffer (PH=8.5). This solution is added to each well and incubated 
for 1h, and then use sodium bicarbonate buffer to wash three times. Finally 1mL 35% 
perchloric acid is added to each well, and absorbance is measure after 8~10 minutes. In 
addition, the absorbance of 1mL 35% perchloric acid in clean wells is also measured as 
a background. The amine group concentration was determined by measuring the 
absorption intensity at 498 nm. 
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4.3 Thickness measurement 
The thickness of LbL films deposited on PVC catheters was measured at dry state 
using an optical profilometer (Zygo). 
5. In vitro MH release in urine 
LbL films were incubated in sterile urine at 37° C for quantification of MH release. 
Every 24 h, the release medium was removed and replaced with fresh urine. The amount 
of MH released at each time point was determined and integrated by Waters 1525 high-
performance liquid chromatography (HPLC). 
5.1 Equipment and chromatographic conditions 
The HPLC device was a Waters 1525 binary HPLC pump with Waters 2489 
UV/Visible detector and a 20 µl injection loop. The system was equipped with a Waters 
C18(3.5μm，4.6*75mm) analytical column. The column was heated to 30℃ with a 
thermostat system. We chose Phosphate buffer (25mM, pH=3), methanol and 
acetonitrile as mobile phase with a ratio of 91:6:3. Samples collected from daily MH 
release of pentalayers were filtered with 0.22µm before injected. The UV/Visible 
detector was set at 245nm wavelength. 
6. Bacterial adhesion study 
6.1 Bacterial culture 
E.coli, A.Baumannii and S. aureus were cultured overnight in agar plates for 24 h 
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at 37℃. 10ul of bacteria were added into 10 mL Trypone Soya Broth (TSB) for E.coli, 
A.Baumannii and S. aureus. These initial cultures were incubated at 37℃ for 24 h. 
After that, 100uL of cultured bacteria suspension was transferred into 10mL TSB 
medium with additional 100uL 50% w/v glucose for seeding. Finally, bacteria were 
seeded onto catheters in 48-well plate, 500ul per well. 
6.2 Bacterial adhesion 
The growth of E.coli, A.Baumannii and S. aureus were observed on bare catheters 
and on anti-adhesion modified catheters coated by (PEI/PSS)10-(PGA-g-PEG/GA)8 . 
100uL was transferred into 10mL TSB medium with additional 100uL 50% w/v glucose 
for seeding. Bacteria were seeded onto catheters in 48-well plate, 500uL per well, and 
incubated overnight for 24 h at 37℃. The bare and anti-adhesion modified catheters 
were washed thoroughly with sterile PBS before XTT assay and morphologic imaging. 
6.3 XTT assay 
XTT was re-suspended from stock solution. Menadione, a catalyst that expedites 
the XTT reaction, was also added. 5% XTT solution and 1.5% menadione were mixed 
in to sterile 1x PBS. Each well (48-well plate) will need 400uL mixed solution. Wash 
the wells with sterile 1x PBS once, then add 500uL mixed solution into each well. 
Incubate the plate for 2 hours. Fluorescence was measured via microplate reader (Tecan) 
at 492nm. Data was adjusted by XTT control and sterile 1x PBS negative control. 
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6.4 DAPI staining and imaging 
Remove the media from the wells. Add sterile 1x PBS to rinse the well. Dilute 
DAPI stock in sterile 1x PBS at the ratio of 1:400. Remove 1x PBS from the wells, add 
400uL DAPI solution into each well (48-well plate). Incubate the plate for 30 min, 
followed by washing by sterile 1x PBS for 3 times. Take fluorescence imaging. Blank 
controls were run simultaneously during each experiment.  
 
7. Cell adhesion study 
7.1 Cell adhesion culture 
RAW 264.7 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM), 
supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, in a 
humidified atmosphere with 5% CO2 at 37 ℃ . To maintain the cells, they were 
normally passed at a ratio of 1: 10 every three days. 
7.2 Staining and counting 
Pieces of sterile urinary catheters were sterilized for 1 h by UV irradiation before 
placing them into a 48-well culture plate for cell culture. Subsequently, RAW 264.7 
were seeded onto the catheters into the wells at a density of 15×104 cells /mL and 
incubated for 24 h. Catheters were then rinsed thoroughly by PBS twice. Then use 
immerse catheters into DAPI stain for 15 min. Wash the catheters with PBS for 3 times 
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before fluorescent imaging. Blank controls were run simultaneously during each 
experiment. Counting cells by Image J. 3 views per replicate, 3 replicates per treatment. 
8. Protein absorption study 
Catheters were put into 48-well plate and immersed by FITC-labeled bovine serum 
albumin (BSA) at a concentration of 200 mg / L which is a risk level indicating a 
possible kidney damage, at 37 ℃ for 24h. Subsequently, catheters were thoroughly 
rinsed with PBS for three times before fluorescent imaging. Blank controls were run 
simultaneously during each experiment. Data for each condition were pooled, and data 
were analyzed for statistical significance. 
9. Microscopy and Image analysis 
Cells were counted by Image J 1.46r. SPSS 20.0 was employed for data statistical 
analysis. 
10. Statistical analysis 
Two-tailed t test was performed to investigate the significance between the contact 
angles, amino groups of each base layer, compared to bare catheter and daily MH 
release between trilayers and pentalayers. Kruskal Wallis test was performed to 
determine the significance of the amount of each bacterial colony, macrophages density 
and protein fluorescent absorption on catheters. A p value < 0.05 was considered 
significant. 
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RESULTS AND DISCUSSIONS 
1. Surface Characterization 
1.1 Measurement of contact angle 
 
Fig. 3.  (A) Contact angle measurement of PEI as base layers with 1, 5, 10 layers. 
Contact angle of bare catheter is also shown in the figure. *, P<0.05, compared to (PEI)5 
(B) Contact angle measurement of PEI as base layers with 1, 5, 10 layers. *, P<0.05, 
compared to (DA)5 (C) Contact angle measurement of PEI/PSS as base layers with 1, 
2, 4, 6, 8, 10 and 12 layers. Contact angle of bare catheter is also shown in the figure. 
*, P<0.05, compared to (PEI/PSS)6. (D) Contact angle of (PEI)10, (PEI/PSS)10, and 
(DA)10. *, P<0.05, compared to (PEI)10 and (DA)10. Data shown are average ±SD (n = 
6). 
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Fig. 3 shows water contact angle of PVC catheter modified with different base 
layers. Bare catheter was hydrophobic with a contact angle of 114.2 ± 1.6°. Fig. 3A 
shows that water contact angle was reduced with increasing number of PEI layers. 
Surface modified with (PEI)10 had significantly lower contact angle than the others. 
Likewise, increasing the number of DA layers resulted in reduced contact angle (Fig 
3B), and 10 layers of DA had the lowest contact angle. Fig. 3C shows that the contact 
angle was reduced as the number of PEI/PSS bilayer was increased. The contact angle 
of (PEI/PSS)6 was significantly higher than that of (PEI/PSS)10. However, there was no 
significant difference between the contact angle of (PEI/PSS)10 and (PEI/PSS)12, 
indicating that increasing the number of bilayers beyond 10 will not further improve 
the surface wettability. Fig. 3D shows that the contact angle of (PEI/PSS)10 was 
significantly lower than that of (PEI)10 and (DA)10, indicating that it is the most 
hydrophilic base layer for PVC catheters. Thus, we chose (PEI/PSS)10 as the base layer 
for the subsequent LbL assembly.  
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1.2 Measurement of amine group surface density 
 
Fig. 4. Measurement of amine group surface density. (A) Sulfo-SDTB measurement of 
PEI as base layer with 1, 5 and 10 bilayers. *, P<0.05, compared to bare catheter. (B) 
Sulfo-SDTB measurement of DA as base layer with 1, 5, and 10 bilayers. *, P<0.05, 
compared to (DA)5. (C) Sulfo-SDTB measurement of PEI/PSS as base layer 1, 2, 4, 6, 
8, 10 and 12 layers. *, P<0.05, compared to (PEI/PSS)8. (D) Amino groups density of 
(PEI)10, (PEI/PSS)10, and (DA)10. *, P<0.05, compared with (PEI)10. Data shown are 
average ±SD (n = 3) 
As DS is negatively charged, a positively charged base layer is required for LbL 
assembly. We measured the surface density of positively charged amino groups on 
different base layers. More amine groups will increase the base layer’s binding affinity 
for DS. , as well as the charge. Fig. 4A and B shows that the surface density of amine 
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groups are similar for 1, 5 and 10 monolayer of PEI, while (DA)10 significantly 
increased amino group density than (DA)1 and (DA)5. For PEI/PSS, amino group 
density increased with the number of bilayers till 10, beyond that the increase in density 
was not significant (Fig 4C). Fig. 4D shows that (PEI)10 has significantly lower anime 
group density compared with (DA)10 and (PEI/PSS)10, whereas that of the latter two 
base layers are significantly different. Combined with the contact angle measurement 
results, (PEI/PSS)10 is the optimal base layer with good hydrophilic and charge density 
(small contact angle and high amino groups density). 
2. Thickness measurement 
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Fig.5 Thickness of and (PEI/PSS)10-PEI-(DS/MH/GA/AS/GC)20 and (DA)10-
(DS/MH/GA/AS/GC)20. *, P<0.05 compared to (DA)10-(DS/MH/GA/AS/GC)20 . Data 
shown are average ±SD (n = 3) 
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Fig. 5 shows that the thickness of 20 pentalayers of MH-releasing film with base 
layer of (PEI/PSS)10 and (DA)10
 is 1.14 ± 0.19 and 1.81 ± 0.22 μm, respectively. Studies 
have shown that the thickness of one layer of PEI/PSS and DA are 3 and 10 nm[5, 23], 
which may contribute to the difference in the total coating thickness. 
 
3. LbL multilayer film growth and characterization 
 
Fig. 6 LbL multilayer film growth and characterization. Data shown are average ±SD 
(n = 3) 
Fig. 6 shows that the UV absorbance of MH increased with the number of 
pentalayers, indicating successful LbL assembly. 
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4. MH release in urine 
 
Fig. 7 MH release in urine. Data shown are average ± SD (n=3). *, P<0.05 compared 
to daily MH release of pentalayers coating. 
 
  Our lab has previously shown that MH release from PEI-(DS/MH/GA)8 deposited 
on UV plates lasted for over 35 days in HBSS. However, after we changed the substrates 
from plates to catheters, the duration of release was drastically reduced to 6 days. When 
we increased the number of trilayers containing MH from 8 to 20, MH release lasted 
for 15 days. Although the duration of drug release was prolonged, it was not enough 
for long-term application. When we changed the base layer from (PEI)1 to (PEI/PSS)10 
to improve the wettability and increase surface charge of the catheters, MH release 
lasted for 31 days in HBSS. However, the release only lasted for 21 days after we 
changed the release medium from HBSS to urine. Molecules in the urine and the 
slightly acidic pH (7.0) may affect the binding affinity of MH to the coating polymers 
and hence, the release rate. We added AS/GC on top of each trilayers to protect tgeh 
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binding of MH to the coating polymers. With the optimized coating design MH release 
in urine for 33 days was accomplished. Moreover, with this new design the initial burst 
release was greatly reduced compared with the trilayer design without AS/GC 
protective layers.  
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5. Anti-bacterial potency of released MH 
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Fig. 8 Anti-bacterial potency of released MH. (A) XTT assay to quantify surviving 
bacteria (E.coli, S.aureus and A.baumannii) on bare catheters and (PEI/PSS)10-PEI-
(DS/MH/GA/AS/GC)20 coated catheters. * P<0.05 compared to bare catheters. Data 
shown are average ±SD (n = 4). Fluorescent images of E.coli cultured on (B) bare 
catheters, and (C) (PEI/PSS)10-PEI-(DS/MH/GA/AS/GC)20 coated catheters after 24h 
culture. The cells were stained with 4',6-diamidino-2-phenylindole (DAPI). 
 
  XTT assay shows that (PEI/PSS)10-PEI-(DS/MH/GA/AS/GC)20 significantly 
inhibited biofilm formation by all three bacteria species (Fig. 8A). The percentage of 
reduction for E.coli, S.aureus and A.baumannii is 91.9 ± 3.7%, 91.2 ± 3.2% and 93.8 ± 
6.1%, respectively. DAPI staining was used to detect the DNA of bacteria. As shown 
in Fig. 8B, E.coli formed biofilm on uncoated catheters, whereas the number of bacteria 
was greatly reduced on the coated catheters, confirming the result from XTT assay. 
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6. Protein adsorption study 
 
Fig. 9 Protein adsorption study. (A) Fluorescence intensity of bovine serum albumin 
(BSA) on bare catheters and (PEI/PSS)10-PEI-(PGA-g-PEG/GA)8 coated catheters. *, 
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P<0.05 compared to bare catheters. Data shown are average ±SD (n = 3). (B) FITC-
BSA on bare catheter. (C) FITC-BSA on anti-adhesive catheter. 
 
The fluorescent intensity, as an indicator of BSA adsorption on (PEI/PSS)10-PEI-
(PGA-g-PEG/GA)8 coated catheters were reduced by 70.1 ± 29.8%. Compared with the 
bare catheters, coated catheters had significantly less BSA adsorption after 24h 
exposure (P<0.01). As proteins play an important role in mediating initial cellular and 
bacterial adhesion onto material surface [33], the anti-adhesive coating developed in 
this study may further contribute to inhibition of infection and inflammation. 
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7. Bacteria adhesion study 
 
Fig. 10 Bacteria adhesion study. (A) XTT assay to quantify bacteria adhesion (E.coli, 
S.aureus and A.baumannii) on bare catheters and (PEI/PSS)10-PEI-(PGA-g-PEG/GA)8 
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coated catheters. *, P<0.05 compared to bare catheters. Data shown are average ±SD 
(n = 4). (B) E.Coli adhesion on bare catheters after 24h culture. (C) E.Coli adhesion on 
(PEI/PSS)10-PEI-(PGA-g-PEG/GA)8 coated catheters after 24h culture. 
 
XTT assay shows that the number surviving E.Coli, a major pathogen causing 
catheter associated urinary tract infection[31], on (PEI/PSS)10-PEI-(PGA-g-PEG/GA)8 
coated catheters was reduced by 71.5 ± 5.3% compared to the control group. The 
numbers of A.Baumannii and S.aureus on coated catheters were reduced by 50.5 ± 33.0% 
and 72.5 ± 10.4%, repectively.  
Most of the bacterial surfaces have hydrophobic regions[34, 35]. Hydrophobic 
interaction seems to be essential for bacterial adhesion[36]. Therefore, the anti-adhevie 
property of our coating could be attributed to the strong hydrophilic PGA-g-PEG chains. 
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8. Macrophage adhesion study 
 
Fig. 11 Macrophage adhesion study. (A) DAPI fluorescent staining to quantify 
macrophage adhesion on bare catheters and (PEI/PSS)10-PEI-(PGA-g-PEG/GA) coated 
catheters. *, P<0.05 compared to (PEI/PSS)10-PEI-(PGA-g-PEG/GA)6. Data shown are 
average ±SD (n = 4). (B)-(H) Remaining mouse macrophage adhesion on bare catheters, 
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(PEI/PSS)10-PEI-(PGA-g-PEG/GA)1, (PEI/PSS)10-PEI-(PGA-g-PEG/GA)2, 
(PEI/PSS)10-PEI-(PGA-g-PEG/GA)4, (PEI/PSS)10-PEI-(PGA-g-PEG/GA)6, 
(PEI/PSS)10-PEI-(PGA-g-PEG/GA)8, (PEI/PSS)10-PEI-(PGA-g-PEG/GA)10 after 24h, 
37℃ culture. 
 
Fig. 11 shows continuous reduction of macrophage adhesion when increasing the 
number of (PGA-g-PEG/GA) bilayers. With 1, 2, 4, 6, and 8 anti-adhesive bilayers, the 
number of macrophages was 79.1 ± 8.1%, 76.7 ± 7.6%, 36.8 ± 8.5%, 27.2 ± 8.5% and 
9.2 ± 4.5% of uncoated control. Further increasing the number of bilayers to 10 did not 
significantly charged the number of adhered macrophages. Thus, 8 bilayers of PGA-g-
PEG/GA is sufficient to effectively inhibit macrophage adhesion. 
PEG has a strong affinity for water molecules[37]. When PEG molecules are 
grafted on the surface of catheter, a layer with hydrated polymer will be formed, 
preventing cell adhesion. Thus, our anti-adhesive coating can potentially inhibit 
activated immune cells to assemble at the implant surface, and thereby prevent 
inflammatory response. 
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CONCLUSIONS 
In this study we developed a novel antibacterial and anti-inflammatory coating for 
urinary catheters that is capable of sustained release of MH in urine for 33 days. MH is 
an effective antibiotic and anti-inflammatory drug. The coating has been shown to 
effectively inhibit biofilm formation by three bacterial species that are relevant to 
urinary tract infection, including multi-drug resistant A. baumannii. We also developed 
an anti-adhesive coating that can effectively inhibit adhesion of protein, bacteria, and 
macrophages. Moreover, all the coating materials are biocompatible polymers that are 
safe for human use. This work provides a reliable and promising approach for 
protecting implanted urinary catheters from infection and inflammation.  
 
FUTURE DIRECTIONS 
We have developed two separate LbL coatings: DS/MH/GA/AS/GC)20, aiming at 
sustained release of MH to inhibit infection after urinary catheter insertion and long-
term use, as well as (PGA-g-PEG/GA)8, aiming at inhibit bacterial and cellular 
adhesion. The two coatings can be combined together to create a more effective 
antibacterial and anti-inflammatory coating. Another important aspect for this research 
is that the substrate we used in this study is PVC catheter. However, silicone catheter is 
more commonly used clinically. In the future, similar study needs to be conducted to 
create a suitable base layer for the silicone catheters, then the combined coating can be 
applied to silicone catheter to test its antibacterial and anti-inflammatory efficacy. 
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